05:23 PM EDT, 07/17/2025 (MT Newswires) -- Douglas F Kling, Chief Operating Officer, on July 15, 2025, sold 98,612 shares in Newamsterdam Pharma ( NAMS ) for $2,096,655. Following the Form 4 filing with the SEC, Kling has control over a total of 44,000 common shares of the company, with 44,000 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1936258/000095017025096665/xslF345X05/ownership.xml